Sort   by:  
 Page size 
UnknownRadiation and Dose-densification of R-CHOP in Primary Mediastinal B-cell Lymphoma: Subgroup Analysis of the UNFOLDER Trial.
Not available
S-EPMC10325764 | biostudies-literature
UnknownSorafenib or placebo in patients with newly diagnosed acute myeloid leukaemia: long-term follow-up of the randomized controlled SORAML trial.
Not available
S-EPMC8410595 | biostudies-literature
UnknownRituximab Maintenance Versus Observation After Immunochemotherapy (R-CHOP, R-MCP, and R-FCM) in Untreated Follicular Lymphoma Patients: A Randomized Trial of the Ostdeutsche Studiengruppe Hamatologie und Onkologie and the German Low-Grade Lymphoma Study Group.
Not available
S-EPMC8221804 | biostudies-literature
UnknownS3-Guideline on Diagnostics, Therapy and Follow-up of Malignant Ovarian Tumours: Short version 1.0 - AWMF registration number: 032/035OL, June 2013.
Not available
S-EPMC3859160 | biostudies-literature
UnknownRadiation and Dose-densification of R-CHOP in Aggressive B-cell Lymphoma With Intermediate Prognosis: The UNFOLDER Study.
Not available
S-EPMC10325769 | biostudies-literature
UnknownLoss-of-Function Mutations of BCOR Are an Independent Marker of Adverse Outcomes in Intensively Treated Patients with Acute Myeloid Leukemia.
Not available
S-EPMC8123716 | biostudies-literature
UnknownImpact of PTPN11 mutations on clinical outcome analyzed in 1529 patients with acute myeloid leukemia.
Not available
S-EPMC8525221 | biostudies-literature
UnknownDifferential impact of IDH1/2 mutational subclasses on outcome in adult AML: results from a large multicenter study.
Not available
S-EPMC8905706 | biostudies-literature
UnknownMYC/MIZ1-dependent gene repression inversely coordinates the circadian clock with cell cycle and proliferation.
Not available
S-EPMC4931031 | biostudies-literature
UnknownGenomic and transcriptomic changes complement each other in the pathogenesis of sporadic Burkitt lymphoma.
Not available
S-EPMC6440956 | biostudies-literature
Sort   by:  
 Page size